A PYMNTS Company

Antitrust Chronicle® – EVERGREENING – AN EVERGREEN ANTITRUST PROBLEM

BY | October 4, 2021

Dear Readers, This CPI issue focuses primarily on two segments, product hopping and pay-for-delay. In the first piece, we look (1) “product hopping” from one version of a drug to…

Dear Readers,

This CPI issue focuses primarily on two segments, product hopping and pay-for-delay. In the first piece, we look (1) “product hopping” from one version of a drug to another and (2) settlements by which brands pay generics to delay entry. Then, we look at regulatory approaches in the EU and U.S. on “evergreening,” FTC’s recent activities, and examine the growing interest outside the United States in getting into the “pay-for-delay” fray, how the Canadian competition au

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 44.200.86.95

Please verify email or join us to access premium content!